The Class II recall covers 3 dosages of clonidine transdermal patches made by Actavis Laboratories, with no adverse health consequences expected ...
Both the delivery system and cited defect are relatively unusual—here's what we know.
The U.S. Food and Drug Administration classified a Teva Pharmaceuticals recall of about 300,133 clonidine transdermal patch ...